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Abstract
Background Approximately half of trauma patients develop post-traumatic depression. It is suggested that beta-
blockade impairs trauma memory recollection, reducing depressive symptoms. This study investigates the effect of
early beta-blockade on depression following severe traumatic injuries in patients without significant brain injury.
Methods Patients were identified by retrospectively reviewing the trauma registry at an urban university hospital
between 2007 and 2011. Severe extracranial injuries were defined as extracranial injuries with Abbreviated Injury
Scale score C3, intracranial Abbreviated Injury Scale score\3 and an Injury Severity Score C16. In-hospital deaths
and patients prescribed antidepressant therapy B1 year prior to admission were excluded. Patients were stratified into
groups based on pre-admission beta-blocker status. The primary outcome was post-traumatic depression, defined as
receiving antidepressants B1 year following trauma.
Results Five hundred and ninety-six patients met the inclusion criteria with 11.4% prescribed pre-admission beta-
blockade. Patients receiving beta-blockers were significantly older (57 ± 18 vs. 42 ± 17 years, p\ 0.001) with
lower Glasgow Coma Scale score (12 ± 3 vs. 14 ± 2, p\ 0.001). The beta-blocked cohort spent significantly longer
in hospital (21 ± 20 vs. 15 ± 17 days, p\ 0.01) and intensive care (4 ± 7 vs. 3 ± 5 days, p = 0.01). A forward
logistic regression model was applied and predicted lack of beta-blockade to be associated with increased risk of
depression (OR 2.7, 95% CI 1.1–7.2, p = 0.04). After adjusting for group differences, patients lacking beta-blockers
demonstrated an increased risk of depression (AOR 3.3, 95% CI 1.2–8.6, p = 0.02).
Conclusions Pre-admission beta-blockade is associated with a significantly reduced risk of depression following
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Symptoms of depression and anxietymay occur in up to half of
all patients following significant trauma, resulting in poorer
outcomes in functional recovery and quality of life [1, 2].
Established depression is difficult to treat and a preventative
measure is therefore in the interest of both patients and trauma
physicians [3]. The mechanisms resulting in clinical depres-
sion are not established but intense emotion around the time of
trauma is of importance for subsequent ‘memory recollection’
and thereby depression maintenance [4]. During memory
retrieval of traumatic events, adrenergic activity is increased in
humans and is manifested as increased heart rate and skin
conduction. These physiologic findings are more significant in
patients diagnosed with post-traumatic stress disorder (PTSD)
[5]. Animal studies show that noradrenaline levels in the
brainstem increase with trauma and amnesia is induced in
rodents that are administered systemic propranolol shortly
after memory recollection [6, 7]. In clinical studies, subjects
who received metoprolol showed diminished physiologic
stress responses when watching a traumatic event and had
impaired memory recall [8]. Consequently, it has been
hypothesized that b-adrenergic receptor activation plays an
important role in the early stages of trauma-induced depression
and indicates a potential therapeutic role for b-blockade (BB)
in trauma patients. BB treatment administered peri- and post-
trauma has been investigated in the context of PTSD and
appears to reduce such symptoms [9–12], but studies are lim-
ited in cohort size and conflicting results have been demon-
strated [13–15]. The effect of pre-injury BB on the
development of clinical depression has not yet been studied,
which is the aim of the current work.
Materials and methods
Ethical approval for this retrospective cohort study was
obtained from the Regional Review Board (Stockholm
County) and the study adhered to the Declaration of Helsinki.
The studycohortwas identifiedbyquerying the trauma registry
of Karolinska University Hospital, an urban university hospi-
tal, for patients admitted to the trauma unit with severe
extracranial injuries (SECI) between January 1, 2007, and
December 31, 2011. SECI were defined as any extracranial
injury (head, neck, thorax, abdomen, extremity, spine) with
Abbreviated Injury Scale (AIS) score C 3, intracranial
AIS\3 and an overall injury burden set by the Injury Severity
Score (ISS) C 16. Individual patient charts were reviewed to
characterize head injuries such that only those patients with a
head AIS of C 3 due to intracranial injury (International
Classification of Diseases 10th Revision S06.1–S06.9) were
excluded. All adult patients (C18 years) were included. In-
hospital deaths were excluded as were patients prescribed
antidepressants up to 1 year prior to the studied admission.
Additional ethical approval was obtained from the National
Board ofHealth andWelfare (Socialstyrelsen) for access to the
national drugs registry database. Informationwas retrieved for
b-blocker therapy 12 months prior to admission and antide-
pressant (selective serotonin reuptake inhibitors, serotonin–
norepinephrine reuptake inhibitors, tricyclic antidepressants
and monoamine oxidase inhibitors) therapy within 12 months
prior and following the hospital stay. Post-traumatic depres-
sion was ascribed to patients given antidepressant therapy
within 1 year of discharge. Patient variables including age,
gender, injury mechanism, AIS, ISS, International Statistical
Classification of Diseases (ICD) 10th version for traumatic
injuries, admission Glasgow Coma Scale (GCS) score, inten-
sive care unit length of stay (ICU LOS) and hospital length of
stay (HLOS) were obtained from the trauma registry. A ret-
rospective review of electronic patient records was carried out
for clinical information during the admission.
Statistical analysis
Demographic and clinical information of the total study
cohort and variable differences between the cohorts
dependent upon pre-admission BB were analyzed using
Chi-squared test for categorical data and Student’s t test, or
Mann–Whitney U test, when appropriate, for continuous
data. For subsequent analysis, continuous variables were
dichotomized based on cutoff points recognized as having
clinical relevance in trauma outcomes: age C 55
vs.\ 55 years, ISS C 25 vs.\ 25, AIS C 4 vs.\ 4,
GCS B 8 vs.[ 8. Bivariate analysis was performed based
on these dichotomous variables. Variables with p B 0.2
from the bivariate analysis were entered into a multivari-
able forward logistic regression model to isolate indepen-
dent risk factors for depression. The study population was
stratified by pre-admission BB exposure, and a multivari-
able logistic regression, adjusted for significant differences
(p B 0.05) between groups, was carried out to examine the
effect of BB on depression. Analysis was performed using
Statistical Package for the Social Sciences (SPSS Macin-
tosh) version 23.
Results
A total of 774 patients with SECI were identified from the
trauma registry and of those 596 met the inclusion criteria.
The mean age was 44 ± 18 years, 82% were male, and
World J Surg
123
89% of injuries were caused by blunt trauma with a mean
ISS of 23 ± 8. Pre-admission BB was prescribed in 11.4%
(n = 68). Comparison of demographics between the b-
blocked group (BB(?)) and the group not prescribed pre-
admission b-blockade (BB(-)), demonstrated that BB(?)
patients were older (57 ± 18, vs 42 ± 17 years,
p\ 0.001) and had lower admission GCS score (12 ± 3 vs
14 ± 2, p\ 0.001) (Table 1). Overall, depression occurred
in 13.8% of patients and the reduction observed in those
who received BB did not reach significance (8.8% vs
14.4%, p = 0.20). The BB group spent more days in
intensive care (4 ± 7 vs. 3 ± 5 days, p = 0.01) and had
longer hospital stays overall (21 ± 20 vs. 15 ± 17 days,
p\ 0.01) (Table 2). Patient variables were entered into a
bivariate analysis. b-Blocker exposure, gender, ISS, AIS,
GCS, abdominal injury, multiple injuries, surgery and
length of ICU and overall hospital stay demonstrated a
plausible association (p B 0.2) with the development of
post-trauma depression (Table 3). In order to determine
independent risk factors for depression, the seven variables
were subsequently entered into a multivariable forward
logistic regression model. As depicted in Table 4, in
addition to the lack of BB exposure (OR 2.7; 95% CI
1.1–7.2; p = 0.04), AIS C 4, GCS B 8 and surgery were
identified as independent risk factors for developing
depression. Following adjustment for significant differ-
ences between the cohorts, the relationship between lack of
pre-admission BB and development of post-trauma
depression was strengthened (AOR 3.3; 95% CI 1.2–8.6;
p = 0.02) (Table 5).
A total of 47 patients had a minor intracranial injury
(AIS B 2) with concomitant severe (AIS C 3) extracranial
injuries. Of these, 11.1% (n = 1) of patients on beta-
blockade developed depression compared to 18.4%
(n = 7) in the non-b-blocked cohort with a p value of 0.60.
A separate multi-regression analysis excluding these
patients and adjusting for differences between the BB(?)
and BB(-) cohorts still resulted in a three times greater risk
of depression in the BB(-) patients (adjusted OR 3.4, 95%
CI 1.3–9.0, p = 0.02).
Discussion
Symptoms of anxiety and depression are common in
patients following severe trauma [1, 16]. It has been
hypothesized that the catecholamine surge occurring at the
time of trauma may be an underlying factor facilitating the
formation of strong emotional memories that are easily
maintained. Ruminating on memories is a significant
Table 1 Demographic differences between patients who were and were not prescribed pre-admission b-blockers
Variable Total n = 596 BB(-) n = 528 BB(?) n = 68 p
Male (%) 82 83 75 0.10
Blunt injury (%) 89 89 93 0.34
Age, mean ± SD 44 ± 18 42 ± 17 57 ± 18 \0.001
Age C 55 years (%) 26 21 59 \0.01
ISS, mean ± SD 23 ± 8 23 ± 8 24 ± 8 0.26
ISS C 25 (%) 33 33 32 0.95
AIS, mean ± SD 3.8 ± 0.7 3.8 ± 0.7 3.8 ± 0.8 0.61
Highest AIS C 4 (%) 60 60 53 0.24
GCS, mean ± SD 14 ± 2 14 ± 2 12 ± 3 \0.001
GCS B 8 (%) 9 5 35 \0.01
Head/spine injury (%) 20 20 18 0.69
With AIS C 4 (%) 75 77 58 0.52
Abdominal injury (%) 23 23 22 0.90
With AIS C 4 (%) 90 90 93 0.68
Thoracic injury (%) 32 32 34 0.76
With AIS C 4 (%) 63 64 57 0.33
Extremity injury (%) 5 6 3 0.35
With AIS C 4 (%) 34 33 50 0.16
Multiple injury (%) 20 20 24 0.48
with AIS C 4 (%) 12 12 6 0.45
BB beta-blockers, ISS Injury Severity Score, AIS Abbreviated Injury Scale, GCS Glasgow Coma Scale
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contributory factor in the development and maintenance of
clinical depression [17, 18]. BB inhibits adrenergic recep-
tor activity and might inhibit the consolidation of such
memories [7]. This inhibition, in turn, could blunt the
emotional effect of traumatic events and prevent post-
injury depression [8]. Interestingly, the use of pindolol
together with serotonergic antidepressants has previously
demonstrated a synergistic effect on negative moods [19].
Regular BB intake also appears to have a protective role in
reducing emotional distress and depressive thoughts in the
Table 2 Clinical outcome differences between patients who were and were not prescribed pre-admission b-blockers
Variable Total n = 596 BB(-) n = 528 BB(?) n = 68 p
Surgery (%) 57 56 60 0.51
ICU LOS, mean days ± SD 3 ± 5 3 ± 5 4 ± 7 0.01
HLOS, mean days ± SD 16 ± 17 15 ± 17 21 ± 20 \0.01
Depression (%) 13.8 14.4 8.8 0.20
BB beta-blockers, ICU LOS intensive care unit length of stay, HLOS hospital length of stay
Table 3 Bivariate relationship between variables and the development of depression with p B 0.2 included in subsequent multivariable analysis
Categorical variable Depression, n (%) OR (95% CI) p
b-Blocker No 76/528 (14.4) 1.7 (0.7–4.1) 0.20
Yes 6/68 (8.8)
Male Yes 63/490 (12.9) 1.5 (0.8–2.6) 0.17
No 19/106 (17.9)
Blunt injury Yes 71/532 (13.3) 0.7 (0.4–1.5) 0.40
No 11/64 (17.2)
Age C 55 years Yes 22/153 (14.4) 1.1 (0.6–1.8) 0.80
No 60/443 (13.5)
ISS C 25 Yes 37/195 (19.0) 1.9 (1.2–3.0) 0.01
No 45/401 (11.2)
Highest AIS C 4 Yes 61/335 (17.2) 2.2 (1.3–3.7) \0.01
No 21/241 (8.7)
GCS B 8 Yes 14/52 (26.9) 2.6 (1.3–5.0) \0.01
No 68/544 (12.5)
Head/spinal injury Yes 16/116 (13.8) 1.0 (0.5–1.8) 0.99
No 66/480 (13.8)
Thoracic injury Yes 24/192 (12.5) 0.9 (0.5–1.4) 0.54
No 58/404 (14.4)
Abdominal injury Yes 24/135 (17.8) 1.5 (0.9–2.5) 0.12
No 58/461 (12.6)
Extremity injury Yes 6/32 (18.8) 1.5 (0.6–3.7) 0.40
No 76/564 (13.5)
Multiple injuries Yes 12/121 (9.9) 0.6 (0.3–1.2) 0.17
No 70/475 (14.7)
Surgery Yes 63/337 (18.7) 2.9 (1.7–5.0) \0.01
No 19/259 (7.3)
Continuous variable No depression Depression Mean difference P
HLOS ± SD 15 ± 16 23 ± 20 7.9 (3.9–11.8) \0.001
ICU LOS ± SD 3 ± 5 4 ± 5 0.9 (-0.4–2.2) \0.01




context of cancer diagnoses as well as following percuta-
neous coronary intervention in ischemic heart disease
[20, 21]. These studies support the current findings that BB
may play a role in the prevention of post-traumatic
depression.
The current study shows that 13.8% of the total cohort
commenced antidepressant therapy within 12 months of
sustaining severe extracranial injury. The incidence of
clinical depression was lower in the group exposed to BB
prior to the traumatic event (8.8%) compared to those who
were not (14.4%). The average prevalence of patients
prescribed antidepressant therapy in the county of Stock-
holm during the studied period (2007–2011) varied
between 9.1 and 9.4% yearly [22]. This suggests that
trauma patients have an increased risk of developing
depression post-trauma. Furthermore, our findings suggest
that depression is a significant comorbidity in the trauma
population and provides data that BB might be effective at
prevention. The mechanism of post-trauma depression is
likely to be multifactorial, and this study identifies four
independent risk factors. Patients who lacked b-blockade
demonstrated a threefold increase in becoming depressed
compared to those who were on the medication. Further,
low GCS on admission, more severe injury and requiring
surgery were associated with increased risk of post-trau-
matic depression.
Interestingly, despite the reduction in patient depression
associated with pre-admission BB, the unadjusted reduc-
tion in the incidence of depression between groups (BB(?)
vs. BB(-)) did not achieve statistical significance
(p = 0.20). However, the unadjusted analysis does not
account for confounding factors such as the fact that
patients who had been prescribed b-blockers had signifi-
cantly longer ICU stays and were older; both factors
associated with depressive syndromes [23, 24]. For
example, trauma patients admitted to the ICU have been
estimated to have a four times greater risk of developing
moderate depression, anxiety or stress symptoms 6 months
post-injury [1]. Additionally, the observed protective effect
of BB in this study increased when adjustment was made
for significant group differences in the logistic regression
model, strengthening the observed impact of BB on the risk
of depression.
While our findings provide support for a possible BB
effect on post-trauma depression, the current retrospective
design does not establish a direct causal link. Further
investigation is required into the mechanisms behind this
effect, and a prospective design examining whether early
b-blockade during the admission itself results in the same
outcome would be of value. Additionally, the national
drugs registry neither keeps record of alternative therapies
for depression such as electroconvulsive or talking/behav-
ioral therapies, nor does it register the medical indication
for prescriptions. Except for the exclusion of patients’
prescribed pre-admission antidepressants, the study design
is unable to control for pre-injury comorbidities such as
anxiety and substance abuse, which may entail a certain
overlap with depressive traits. Finally, the study does not
control for the type of b-blocker (i.e., selective vs. non-
selective and lipophilic vs. hydrophilic) although over 70%
of patients were prescribed metoprolol. Due to this over-
whelming majority, all patients with prescribed b-blockers
were treated identically and no subgroup analyses were
performed. However, since lipophilic b-blockers are able
to cross the blood–brain barrier, this subgroup may be of
greater relevance in the context of depression prevention. A
subsequent study subgrouping different types of BB might
therefore be of value.
Conclusion
The exposure to pre-admission b-blockers significantly
reduces the risk of developing depression by a factor of
three up to 1 year following severe traumatic extracranial
injury. Further investigation is needed to explore whether
b-blockade in these instances may have a prophylactic, or
possibly therapeutic, role.
Table 4 Independent predictors for depression by multivariable
logistic regression
Step Variable OR (95% CI) p
1 Surgery 2.9 (1.7–5.0) \0.01
2 Highest AIS C 4 2.1 (1.3–3.6) \0.01
3 GCS B 8 2.1 (1.1–4.2) 0.03
4 No pre-admission b-blocker 2.7 (1.1–7.2) 0.04
The following variables were included in the multivariable analysis:
beta-blocker, gender, ISS, GCS, AIS, abdominal injury, multiple
injuries, surgery, hospital and ICU length of stay
AIS Abbreviated Injury Scale, GCS Glasgow Coma Scale







No pre-admission b-blocker 76/528 (14.4) 3.3 (1.2–8.6) 0.02
Pre-admission b-blocker 6/68 (8.8)
The following variables were adjusted for in the regression analysis:
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